SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: June 11, 1999
Express Scripts, Inc.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as specified in its Charter)
Delaware 0-20199 43-1420563
- --------------------------------------------------------------------------------
(State or other (Commission File No.) (I.R.S. Employer
jurisdiction of Identification No.)
corporation)
13900 Riverport Drive, Maryland Heights, Missouri 63043
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (314) 770-1666
---------------------------
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On June 11, 1999, Express Scripts, Inc. issued a press release, a copy of
which is attached hereto as Exhibit 99.1, and incorporated herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) The following exhibit is filed as part of this report on Form 8-K:
Exhibit 99.1 Press release, dated June 11, 1999, by Express Scripts, Inc.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EXPRESS SCRIPTS, INC.
Date: June 24, 1999 By: /s/ Barrett A. Toan
Barrett A. Toan
President and Chief Executive Officer
<PAGE>
EXHIBIT INDEX
Exhibit No. Description
99.1 Press release, dated June 11, 1999, by Express Scripts, Inc.
<PAGE>
EXHIBIT 99.1
EXPRESS SCRIPTS COMPLETES DEBT OFFERING
ST. LOUIS, JUNE 11, 1999 -- Express Scripts, Inc. (NASD: ESRX) today
announced that it has completed the sale of $250 million of 9-5/8% Senior Notes
Due 2009 through a private placement to qualified institutional buyers. The
notes are not registered under the Securities Act and may not be offered or sold
in the United States without registration or an applicable exemption from the
registration requirements under the Act. The company will use the net proceeds
of approximately $243.5 million to refinance a portion of the term loan under
its existing credit facility. Express Scripts, Inc. is the nation's leading
independent full-service pharmacy benefit management (PBM) and specialty managed
care company. Through facilities in seven states and Canada, the company serves
thousands of clients throughout North America, including managed care
organizations, insurance carriers, third-party administrators, employers and
union-sponsored benefit plans. Express Scripts is headquartered in St. Louis,
Mo.
